The Manufacturers Life Insurance Company Takes Position in Acadia Healthcare Company, Inc. $ACHC

The Manufacturers Life Insurance Company purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 44,845 shares of the company’s stock, valued at approximately $1,324,000.

Several other institutional investors have also recently added to or reduced their stakes in ACHC. EverSource Wealth Advisors LLC grew its holdings in Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Allworth Financial LP acquired a new stake in shares of Acadia Healthcare in the 2nd quarter valued at about $45,000. Wells Fargo & Company MN lifted its position in shares of Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares during the last quarter. Global Retirement Partners LLC acquired a new position in Acadia Healthcare in the second quarter worth about $68,000. Finally, Quantbot Technologies LP acquired a new position in Acadia Healthcare in the second quarter worth about $88,000.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Barclays upped their price objective on Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research note on Thursday, July 30th. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Guggenheim boosted their price target on Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 30th. TD Cowen raised their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Finally, KeyCorp lifted their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $29.85.

Acadia Healthcare Stock Down 0.9%

Acadia Healthcare stock opened at $28.13 on Friday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $35.83. The company has a 50-day simple moving average of $30.70 and a 200-day simple moving average of $26.51. The firm has a market capitalization of $2.62 billion, a P/E ratio of -2.26, a P/E/G ratio of 9.14 and a beta of 0.62.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. During the same period last year, the firm posted $0.83 EPS. Acadia Healthcare’s quarterly revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities analysts expect that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.